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Summary
Mycotoxins are today considered one of the main contaminants of food and feed. 
Widespread zearalenone and its metabolites have potent estrogenic and anabolic ac-
tivity, proven in numerous studies worldwide. Th e aim is to investigate infl uence of 
zearalenone on the uterine weight of rats depending on the applied dose and duration 
of the observation period. In a controlled experimental study, 63 adult female Wistar 
rats were divided into three groups, depending on the oral test dose of zearalenone 
applied: 0.1, 0.3 and 0.5 mg / kg of body weight. At the end of each of the four obser-
vation periods of seven days, animals were sacrifi ced under general anesthesia with 
ether, and aft er an autopsy the mass of the uterus was determined. Zearalenone in the 
dose of 0.1 mg / kg of body weight has caused a signifi cant increase in uterine weight 
between the fi rst and fourth observation interval. Doses of 0.3 and 0.5 mg zearale-
none / kg caused a decrease in uterine weight, which was at a dose of 0.5 mg / kg high-
ly signifi cant between all observational intervals. Aft er 7 days of applying of the toxin, 
uterine weights did not diff er signifi cantly with respect to applied dose. Aft er 14, 21 
and 28 days, diff erences in uterine weight were highly signifi cant, depending on the 
dose of zearalenone. Th e results show that prolonged application of large doses of zea-
ralenone produced a signifi cant decrease in uterine weights in experimental animals.
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Introduction
Many chemicals of anthropogenic origin, as well as com-
pounds that occur naturally, such as mycotoxins including 
zearalenone, can enter the food chain and cause various health 
disorders in humans and animals. In recent years, the presence 
of estrogenic substances in food, either as natural constituents, 
either as contaminants, caused an increase of attention because 
of the presumed possible etiological role in the development of 
some diseases.
Zearalenone, a product from the mold Fusarium, known as 
non-steroidal estrogenic mycotoxin, shows strong uterotropic 
activity in most animals. Th is mycotoxin and its metabolites 
α-and β-zearalenol belong to a rare group of natural products, 
β-resorcylic acid lactones, which are capacity to bind to estro-
gen receptors of the uterus due to the chemical identity of the 
estradiol. Th e reactions of animals to zearalenone application 
or taking zearalenone with food depends on a number of fac-
tors, primarily on the type of animal. So the pigs are more sen-
sitive to zearalenone (Obremski et al., 2003; Zwierzchowski et 
al., 2005) compared to rats, poultry and cattle (Fitzpatrick et al., 
1989; Weaver et al., 1986).
Studies on various animal species have demonstrated that 
zearalenone and its metabolites have strong estrogenic and ana-
bolic activity (Kuiper-Goodman et al., 1987). Zearalenone and 
its metabolites showed competitive binding to estrogen recep-
tors in the uterus during the numerous in vitro experiments. A 
study conducted by Katzenellenbogen et al. (1979) demonstrated 
the direct interaction of estrogen receptor and the nature of the 
biological activities of three estrogen Resorcylic acid lactone (P-
1492 zearalenone) or its derivatives (P-1496 and P-1560 epimer-
ic zearalenone) in the immature rat uterus. Th ese compounds 
“compete” with estradiol for cytoplasmic receptors. Similar 
studies were made by Mitak et al. (2002) by feeding rats over 5 
day period during estrus. Th e animals were fed zearalenone at 
a dose of 2.5 mg / kg body weight, the number of receptor rela-
tionships for H-estradiol to uterine cytosol was observed. Th e 
results indicate that the zearalenone competes with β-estradiol 
for binding to estrogen receptors of the uterus. Fitzpatrick et al. 
(1989) investigated the binding affi  nity of α and β-zearalenol, and 
the estrogenic eff ect in the uterus and fallopian tubes in various 
animals (rats, pigs and chickens), as indicators of estrogenic po-
tential. Th e results showed that the relative binding affi  nity may 
be partially explained by diff erences in the sensitivity of diff er-
ent species of animals to zearalenone food intake. Th us, the rela-
tive binding affi  nity of α-zearalenol was 10-20 times higher than 
zearalenone, and about 100 times larger than the β-zearalenol, 
while the binding affi  nity of α-zearalenol was higher in pigs than 
in rats and chickens.
During the years, there are more frequent reports about the 
harmful eff ects of zearalenone in humans and animals (Ewald 
et al., 1991). Zearalenone toxicosis of animals usually occurs 
periodically during the early occurrence of rainy autumns and 
particularly described in pigs (Ozegovic and Pepenjak, 1995; 
Ozegovic, 1989). Oft en it is suspected that reproductive disorders 
in domestic animals and hyperestrogenic syndromes in humans 
are caused by intake of zearalenone (Agog, 2004). Reaction of 
certain organs in experimental animals aft er intake of zearale-
none is diff erent (Becci et al, 1982). Th e body of the uterus with 
endometrium are the most sensitive parts of the female repro-
ductive tract that are exposed to adverse eff ects of zearalenone. 
Th ere are many pathological disorders of that organ, oft en chronic 
and recurrent nature (Kumar et al., 1994). Zearalenone and its 
metabolites during numerous in vitro experiments showed com-
petitive binding to estrogen receptors in the uterus. It is proved 
that the toxin causes an increase in the uterus and mammary 
glands, swelling of the vulva, testicular atrophy, and hatching 
the birth canal in rats, mice, and guinea pigs (Ruddick et al., 
1976). Disorders also include reduction in fertility, damage to 
the reproductive tract, increased embryonic resorption, chang-
es in weight of adrenal, thyroid, and pituitary glands, changes 
in serum levels of progesterone and 17β-estradiol (Zinedine et 
al., 2007; WHO, 2000).
Toxicological studies of testing the eff ects of zearalenone 
in experimental animals are the basis for defi ning their maxi-
mum permitted concentration in food and animal feed in order 
to protect human and animal health.
Th e work aims to determine the eff ect of oral administration 
of zearalenone on the rat uterine weight, depending on the ap-
plied dose and duration of the observation period.
Material and methods
Testing was conducted on 68 female Wistar rats aged cca 
two months, bred at the Department of Pharmacology and 
Toxicology of Veterinary Faculty of Sarajevo University. Th e 
tested animals were divided into groups: A (22 specimens), B 
(23) and C (23), depending on the dose of a given toxin. Th ree 
levels were determined: 0.1 mg / kg body weight (group A), 0.3 
mg / kg body weight (group B) and 0.5 mg / kg body weight 
(group C). The experiment used a pure toxin zearalenone 
(Sigma-Z-2125 EECNo241-864-O). Zearalenone was applied 
peroraly (through gastric sonde) at regular intervals (24-hour 
cycle). Observation period (duration of application) included 
four diff erent time intervals: I - 7 days, II - 14 days, III - 21 day, 
and IV - 28 days. Th e animals were sacrifi ced every seven days 
(aft er the last day of giving the toxins) under a glass bell in the 
general-ether anesthesia, as follows: the 5 animals from each 
group aft er 7 days, 5 animals from group A and 6 from group B 
and C aft er 14 days and fi naly 6 animals from each group aft er 
21 and 28 days. Aft er sacrifi cing the dissection and inspection 
of body cavities and organs was approached towards to detect 
macroscopic changes. Aft er the fi rst cut along the mediosagit-
tal line, ovarian and the third lateral Fallopian tube dissection 
was performed, as well as uterus on the line of demarcation of 
the body and cervix by groups.
Th e measured values of the mass of the uterus are described 
in the measures of central tendency and variability measures, 
and with Kruskal-Wallis’s test and intergroup comparison, sig-
nifi cant diff erences in uterine weight were compared to applied 
dose and duration of the observation period was estimated. 
Diff erences at p<0.05 were considered statistically signifi cant 
and highly statistically signifi cant at p<0.01.
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Results
Uterine weight depending on the applied dose
Aft er 7 days of application of diff erent doses of zearalenone, 
uterine weight of rats did not diff er signifi cantly: T=0.24 and 
p>0.05 (Table 1).
Aft er 14 days of applying diff erent doses of of zearalenone, 
uterine weight in rats statistically highly signifi cant diff ered: 
T=14.23 and p<0.01 (Table 2). Intergroup diff erences of uterine 
weight, depending on the dose (less weight of the uterus asso-
ciated with a higher dose of the toxins) were also statistically 
highly signifi cant (p<0.01).
Aft er 21 days of applying diff erent doses of of zearalenone, 
uterine weight in rats statistically highly signifi cant diff ered: 
T=15.17 and p<0.01 (Table 3). Intergroup diff erences of uterine 
weight, depending on the dose (less weight of the uterus asso-
ciated with a higher dose of the toxins) were also statistically 
highly signifi cant (p<0.01).
Aft er 28 days of applying diff erent doses of of zearalenone, 
uterine weight in rats statistically highly signifi cant diff ered: 
T=15.15 and p<0.01 (Table 4). Intergroup diff erences of uterine 
weight, depending on the dose (less weight of the uterus asso-
ciated with a higher dose of the toxins) were also statistically 
highly signifi cant (p<0.01).
Weights of the uterus, depending on the duration of 
the observation period
Uterine weight of rats in Group A, treated with zearalenone 
of 0.1 mg / kg, increased during the observational interval, but 
not statistically signifi cant (t=5.585, p>0.05). Th e only statisti-
cally signifi cant diff erence was between 7th and 28th day: p<0.05 
(Table 5).
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7 5 0.81 0.63 0.94 0.14
14 5 0.87 0.84 0.94 0.04
21 6 0.87 0.84 0.90 0.02
28 6 0.91 0.87 0.94 0.04




7 5 0.83 0.63 1.02 0.16
14 6 0.80 0.78 0.84 0.03
21 6 0.78 0.75 0.83 0.04
28 6 0.78 0.74 0.82 0.03
 Days n Uterine masses (g) S.D.
x min. max. 
C group 
(0.5 mg/kg) 
7 5 0.84 0.62 1.03 0.17
14 6 0.71 0.69 0.76 0.03
21 6 0.63 0.61 0.65 0.02
28 6 0.57 0.54 0.59 0.02
Table 1. Uterine masses aft er 7 days of application of 
zearalenone
Table 2. Uterine masses aft er 14 days of application of 
zearalenone
Table 3. Uterine masses aft er 21 days of application of 
zearalenone
Table 4. Uterine masses aft er 28 days of application of 
zearalenone 
Table 5. Uterine masses of rats in group A aft er the 
observational interval
Table 6. Uterine masses of rats in group B aft er the 
observational interval
Table 7. Uterine masses of rats in group C aft er the 
observational interval
Uterine weight of rats in Group B, treated with zearalenone 
of 0.3 mg / kg, decreased during the observational interval, but 
not statistically signifi cant: T=1.78 and p>0.05 (Table 6).
Uterine weight of rats in Group C, treated with zearalenone 
of 0.5 mg / kg, decreased statistically highly signifi cant during 
the observational interval T=17.72 and p<0.01 (Table 7). Th e only 
not statistically signifi cant (p>0.05) was diff erence between 7th 
and 14th day of application.
Agric. conspec. sci. Vol. 77 (2012) No. 3
140 Sejad MACKIC, Nihada AHMETOVIC
Discussion
It was determined that Fusarium toxins, particularly zea-
ralenone, cause numerous toxic eff ects, both in laboratory and 
in domestic animals. Zearalenone originating from food show 
estrogenic eff ects in vitro and acts via estrogen receptor mecha-
nism. In numerous studies worldwide zearalenone estrogen ef-
fects on reproductive organs of animals, especially the uterus 
has been proven. Rats belong to a group of animals that show 
sensitivity to estrogenic eff ects of zearalenone. Th e research of 
Beccia et al. (1982) showed signifi cant increase in uterine masses 
in rats at exposure doses of 3 mg / kg body weight per day. In 
female rats, average weight 175-200 g, aft er application of zea-
ralenone subcutaneously, during 3 days at a dose of 0.2 mg / kg, 
there was an increase of uterine masses (Turcotte et al., 2005). 
Dose of of 250 mg / kg used in the experiment in the diet of rats 
aged 23 days and 48 hours signifi cantly increases the weight of 
the uterus (James and Smith, 1982; Smith, 1980) that confi rms 
that the uterus is one of the sensitive organs to the mycotoxin 
zearalenone. Th is is in agreement with the results of our study. 
Zearalenone estrogenic eff ect on the uterus depends on the 
dose and period of application, which we confi rmed in our re-
search. In the group of rats that were treated with 0.5 mg zea-
ralenone / kg body weight we found that the value of uterine 
weight was signifi cantly reduced during all observational pe-
riods, and that on the 28th day was the smallest. Larger doses 
of zearalenone caused a signifi cantly greater decrease in uter-
ine weight. Similar results were showed by Ruzsás et al. (1979). 
In rats who ate maize contaminated with molds that produce 
toxin, decreased gonad weight has been shown. However, the 
study of the eff ects of dietary exposure of zearalenone on the 
uterus of rats (doses of 0.03 to 1.0 mg / kg body weight) showed 
an increase in uterine weight depending on the dose, and sig-
nifi cant increase was observed aft er three days exposure to the 
highest doses (Heneweer et al., 2007). In our study a signifi cant 
increase in uterine weight at doses of 0.1 mg zearalenone / kg 
body weight between 7 and 28 days of application was concluded.
Also in other species of animals uterus activity of zearale-
none has been demonstrated. In pigs that were fed corn con-
taining zearalenone for 70 days at a dose of: 0.01, 0.06, 0.15, 0.22 
and 0.42 mg / kg, the highest dose had signifi cantly increased 
mean weight of the uterus immediately aft er sacrifi ce (Döll et al., 
2004). Contaminated corn (1.2 mg zearalenone / kg maize) was 
administered to pigs, and it was observed that the mean uterine 
weight increased (Döll et al., 2003). In young pigs of both sexes 
who received oral doses of 5, 10 and 15 mg / kg of body weight 
of purifi ed zearalenone, seven days aft er application it was es-
tablished that the reproductive organs of females had four times 
more mass than the control group (Farnworth and Trenholm, 
1983). Lopez et al. (1988) in Argentina were fi rst to prove poi-
soning of twenty pigs that were fed corn containing 56 ppm of 
zearalenone. Poisoned animals had signs of zearalenone estro-
genic eff ects such as increased mammary glands, swelling of the 
vagina and increase of weight of reproductive organs.
Conclusions
– Intergroup diff erences in uterine weight depending on the 
applied dose of zearalenone were statistically highly signifi -
cant diff erent aft er 14, 21 and 28 days, with smaller uterine 
masses statistically highly signifi cant associated with a higher 
dose of zearalenone. 
– Zearalenone in the test dose of 0.1 mg / kg caused increased 
uterine mass that was statistically signifi cant between the 
7th and 28th day. Th e test dose of 0.3 mg / kg caused a de-
crease in uterine masses that was not statistically signifi cant 
between observational interval. Th e test dose of 0.5 mg / kg 
caused a statistically highly signifi cant decrease in uterine 
mass during all observational periods.
– Zearalenone is modeling uterine weight in rats depending 
on the dose and duration of application.  
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